Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo- Controlled Clinical Trials

被引:0
|
作者
Joshi, S. [1 ]
Smith, T. [2 ]
Pavlovic, J. [3 ]
Mullin, K. [4 ]
Croop, R. [5 ]
Mosher, L. [6 ]
Lovegren, M. [6 ]
Forshaw, M. [6 ]
Lipton, R. [3 ]
机构
[1] Community Neurosci Serv, Westborough, MA USA
[2] Study Metrix Res, St Petersburg, FL USA
[3] Albert Einstein Coll Med, Bronx, NY USA
[4] New England Inst Neurol & Headache, Stamford, CT USA
[5] Pfizer Inc, New York, NY USA
[6] Biohaven Pharmaceut, New Haven, CT USA
来源
HEADACHE | 2023年 / 63卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-73
引用
收藏
页码:137 / 138
页数:2
相关论文
共 50 条
  • [41] Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies
    Ashina, Messoud
    Vasudeva, Raghavendra
    Jin, Leah
    Lombard, Louise
    Gray, Elizabeth
    Doty, Erin G.
    Yunes-Medina, Laura
    Kinchen, Kraig S.
    Tassorelli, Cristina
    [J]. HEADACHE, 2019, 59 (10): : 1788 - 1801
  • [42] Asenapine efficacy, safety, and tolerability in the treatment of acute schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, SG
    Cohen, M
    Panagides, J
    Jina, AS
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 154S - 154S
  • [43] A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
    Graft, D
    Aaronson, D
    Chervinsky, P
    Kaiser, H
    Melamed, J
    Pedinoff, A
    Rosen, JP
    Schenkel, EJ
    Vandewalker, ML
    Keim, A
    Jensen, PK
    Nolop, K
    MesarinaWicki, B
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (04) : 724 - 731
  • [44] Onabotulinumtoxin-A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical program
    Dodick, D. W.
    Aurora, S. K.
    DeGryse, R. E.
    Turkel, C. C.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H-C
    Brin, M. F.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S14 - S14
  • [45] Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine - A randomised, double-blind, placebo-controlled study
    Dodick, D
    Brandes, J
    Elkind, A
    Mathew, N
    Rodichok, L
    [J]. CNS DRUGS, 2005, 19 (02) : 125 - 136
  • [46] Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials
    Kane, John M.
    Durgam, Suresh
    Satlin, Andrew
    Vanover, Kimberly E.
    Chen, Richard
    Davis, Robert
    Mates, Sharon
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 244 - 250
  • [47] The Relative Efficacy of Meperidine for the Treatment of Acute Migraine: A Meta-analysis of Randomized Controlled Trials
    Friedman, Benjamin W.
    Kapoor, Alok
    Friedman, Matt S.
    Hochberg, Michael L.
    Rowe, Brian H.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2008, 52 (06) : 705 - 713
  • [48] The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
    Xinyu Tao
    Zeya Yan
    Jiahao Meng
    Wei Wang
    Qiling Dai
    Qiufeng Zhou
    Zhifeng Wang
    Zhong Wang
    [J]. The Journal of Headache and Pain, 2022, 23
  • [49] The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
    Tao, Xinyu
    Yan, Zeya
    Meng, Jiahao
    Wang, Wei
    Dai, Qiling
    Zhou, Qiufeng
    Wang, Zhifeng
    Wang, Zhong
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [50] Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials
    Wang, Qinghui
    Wang, Shuangmei
    Zhu, Yi
    Lin, Fei
    [J]. FRONTIERS IN NEUROLOGY, 2023, 14